- Home
- ABUS vs RGR Comparison
ABUS vs RGR Comparison
Compare ABUS & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- RGR
- Stock Information
- Founded
- ABUS N/A
- RGR 1949
- Country
- ABUS United States
- RGR United States
- Employees
- ABUS N/A
- RGR N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- RGR Ordnance And Accessories
- Sector
- ABUS Health Care
- RGR Industrials
- Exchange
- ABUS Nasdaq
- RGR Nasdaq
- Market Cap
- ABUS 697.3M
- RGR 610.8M
- IPO Year
- ABUS N/A
- RGR N/A
- Fundamental
- Price
- ABUS $3.21
- RGR $34.97
- Analyst Decision
- ABUS Strong Buy
- RGR
- Analyst Count
- ABUS 4
- RGR 0
- Target Price
- ABUS $5.50
- RGR N/A
- AVG Volume (30 Days)
- ABUS 903.4K
- RGR 206.4K
- Earning Date
- ABUS 11-06-2024
- RGR 02-19-2025
- Dividend Yield
- ABUS N/A
- RGR 1.98%
- EPS Growth
- ABUS N/A
- RGR N/A
- EPS
- ABUS N/A
- RGR 1.73
- Revenue
- ABUS $6,742,000.00
- RGR $520,485,000.00
- Revenue This Year
- ABUS N/A
- RGR N/A
- Revenue Next Year
- ABUS N/A
- RGR $4.81
- P/E Ratio
- ABUS N/A
- RGR $20.17
- Revenue Growth
- ABUS N/A
- RGR N/A
- 52 Week Low
- ABUS $2.21
- RGR $34.84
- 52 Week High
- ABUS $4.72
- RGR $48.20
- Technical
- Relative Strength Index (RSI)
- ABUS 33.77
- RGR 29.63
- Support Level
- ABUS $3.13
- RGR $35.61
- Resistance Level
- ABUS $3.61
- RGR $37.21
- Average True Range (ATR)
- ABUS 0.17
- RGR 0.91
- MACD
- ABUS -0.03
- RGR -0.11
- Stochastic Oscillator
- ABUS 12.12
- RGR 4.01
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.